<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>A calpain unique alveolates essential in <br /> Plasmodium falciparum knockdown reveals <br /> an involvement pre-S-phase development <br /> Ilaria Russo, Anna Oksman, Barbara Vaupel, Daniel E. Goldberg1 <br /> Departments Medicine Molecular Microbiology, Howard Hughes Medical Institute, Washington University School Medicine, <br /> 660 South Euclid Avenue, St. Louis, MO 63110 <br />  <br /> Edited Anthony Cerami, Warren Pharmaceuticals, Ossining, NY, approved November 21, 2008 (received review July 18, 2008) <br />  <br /> Plasmodium falciparum encodes single calpain distinct           undertook genetic characterization assess essentiality and <br /> domain composition restricted alveolates. <span id='am-6' about='protege:TO' typeof='owl:Thing'>To</span> evaluate                 gain insight function cell. <br /> potential protein drug target, assessed essen-              We report Pcalp distinct type calpain restricted to <br /> tiality. Both gene disruption double cross-over gene trun-            alveolates. Using multiple approaches, gene is <br /> cation single cross-over recombination failed. We               essential intraerythrocytic parasites. By developing conditional <br /> unable achieve allelic replacement using <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span>missense mutation</span>           knockdown system, able examine gene function. <br /> at catalytic cysteine codon, obtain synon-             Pcalp plays critical role cell cycle progression tropho- <br /> ymous allelic replacement parasites. These results suggested            zoite development. <br /> the calpain gene proteolytic activity important for <br /> optimal parasite growth. To gain insight biological         Results <br /> role, used FKBP degradation domain generate               Pcalp Is Distinct Type Calpain Restricted Alveolates. We <br /> fusion protein stability transfected parasites             identified single calpain gene (Pcalp) P. falciparum, <br /> modulated small FKBP ligand, Shield1 (Shld1). We                 MAL13P1.310 locus. The predicted coding region 6,147 bp, <br /> calpain-GFP-FKBP fusion single cross-over integration             encodes 242-kDa protein, confirmed extensive se- <br /> the endogenous calpain locus. Calpain levels knocked               quence analysis genomic DNA cDNA amplified <span id='am-3' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> and parasite growth greatly impaired absence Shld1.            mature mRNA (SI Materials Methods). Orthologs Pcalp were <br /> Parasites delayed ability transition ring        Plasmodium species sequence data are <br /> stage ability progress S phase. Calpain            available (Table S1). By phylogenetic analysis confirmed that <br /> required cell cycle progression Plasmodium parasites              Pcalp greatest homology Aspergillus PalB (2), limited the <br /> appears attractive drug target. We shown                  catalytic domain. However, low reliability node derivation <br /> regulated knockdowns possible P. falciparum                indicates substantial divergence (Fig. 1). In fact, aside central <br /> useful evaluating essentiality function.                             calpain catalytic domain (IIa-b) C-terminal domain homol- <br />                                                                              ogous calpain domain III, Pcalp possesses long N terminus that <br /> cell cycle &#229;&#8230;&#169; cysteine protease &#229;&#8230;&#169; essentiality &#229;&#8230;&#169; inducible &#229;&#8230;&#169; malaria          significant homology known protein. Pcalp distinct <br />                                                                              type calpain domain composition, common any <br />  <br /> P    lasmodium falciparum, causative agent severe malaria, <br />      complex life cycle involving numerous biological events, <br /> such migration, host cell invasion, metabolism, cell cycle <br />                                                                              identified calpain class (Fig. 1). <br />                                                                                All sequenced apicomplexan parasite genomes encode single <br />                                                                              calpain N-terminal homology, the <br /> progression egress. Cysteine proteases implicated           gene predictions result shorter encoded N terminus (Fig. 1). <br /> most processes (1), function of                 Two ciliate calpains, Tetrahymena Paramecium, have <br /> estimated 35 members protease class encoded genome            N termini homology Pcalp. Bootstrap analysis and <br /> has defined. Among single calpain-like protease           domain composition indicate Pcalp belongs distinct clade <br /> recognized (2).                                                              calpains restricted Apicomplexa alveolates <br />    Calpains belong C2 family cysteine proteases. Calpains          (Fig. 1). The diatom Thalassiosira pseudonana, belongs the <br /> are organisms bacteria mammals exhibit great            chromalveolate kingdom, encoded calpain distant <br /> divergence sequence domain structure homologous              N-terminal homology alveolate sequences (not shown). <br /> catalytic domains. Calpains implicated diverse pro- <br /> cesses (3&#226;&#8364;&#8220;6), muscle function, cell signaling, migration         Pcalp Is Expressed Early Intraerythrocytic Stages. Because pub- <br /> attachment, death, transformation, cell-cycle regulation, differen-          lished Pcalp mRNA assessments differ (9, 10), we <br /> tiation development, fungal alkali tolerance,           analyzed cDNA semiquantitative RT-PCR asexual <br /> precise physiological role of calpains poorly         development. Amplifying N-terminal C-terminal <br /> understood (3, 7). <br />    Calpains divided typical (resembling calpain 1) and <br /> atypical (lacking domain IV) (4, 5). In typical calpains, domain IV          Author contributions: I.R. D.E.G. designed research; I.R., A.O., B.V. performed <br /> mediates Ca2&#226;&#171;&#185; binding consequently activity regulation               research; I.R. D.E.G. analyzed data; I.R. D.E.G. wrote paper. <br />  <br /> dimerization (8). In P. falciparum, 1 calpain gene (Pcalp)           The authors declare conflict interest. <br /> apparent genome (2), atypical. It unusually          This article PNAS Direct Submission. <br /> long coding sequence, outside catalytic domain,          Freely available online PNAS open access option. <br /> distant homology characterized calpains. We Pcalp            Data deposition: The sequences reported paper deposited GenBank <br /> contains subdomains highly conserved related             database (accession nos. EF432831, EF432832, EF432833). <br /> species confer uniqueness protein. One deter-             1To   correspondence addressed. E-mail: goldberg@borcim.wustl.edu. <br /> mines nucleolar localization, regulates calpain move-            This article contains supporting information online www.pnas.org/cgi/content/full/ <br /> ment nucleus reversible palmitoylation             0806926106/DCSupplemental. <br /> (I.R., unpublished data). Surprised location Pcalp,             &#194;&#169; 2009 The National Academy Sciences USA <br />  <br />  <br />  <br /> 1554 &#226;&#8364;&#8220;1559 &#229;&#8230;&#169; PNAS &#229;&#8230;&#169; February 3, 2009 &#229;&#8230;&#169; vol. 106 &#229;&#8230;&#169; no. 5                                                         www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0806926106 <br />      A                                                                                                      B <br />                    0.05                                    Domains-&gt; N-terminal Catalytic <br />                                                                                 IIa IIb     III   IV <br />                                               Drosoph_CalpC <br />                                        Schisto_Calp                                                                                                                    Domains-&gt; N-terminal Catalytic <br />                                                                                                                                                                                              IIa IIb III <br />                          68            Human_Calp9                                                             0.05 <br />                                                                                                                                     100                      P. falciparum <br />                    77                 Human_Calp3                                                                            100 <br />                         62     58      Murine_Calp8                                                                                                         P. reichenowi <br />                              95        Human_Calp2                                                                                                          P. gallinaceum <br />          63 <br />                                       Human_Calp1                                                                            99 <br />               63         72                                                                                                                                 P. chabaudii <br />                     50                 Human_Calp11                                                                                 100 <br />                                 100    Drosoph_CalpA                                                                         55                              P. yoelii <br />               40                       Drosoph_CalpB                                                                                100                      P. berghei <br />                     37                 C.elegans_clp-7 <br />         80 <br />                                        Human_Calp12                                                                                100                         P. vivax <br />              52                          Human_Calp13                                                                  100                                   P. knowlesi <br />                                         C.elegans_Tra3                                            C2 <br />                98 <br />                                         Human_Calp5                                                                                 100                              N. caninum <br />     48                                                                                                                       100 <br />                    66                      Human_Calp6                                                                                                            T. gondii <br />                                            Human_Calp10 <br />                                                                     ZnF_RBZ               SOLH                    98                                              E. tenella <br />                          100             Drosoph_CalpD <br />          62                              Human_SOLH TMs                                                                 70                                        B.bigemina <br />                                                                                                                              97 <br />                                        Arabid._Dek1                                                                                                                  T. annulata <br />                                                                                           LyM                                                               100 <br />         26                               Entamoeba_Calp <br />          64                                Trypanosome_Calp                                                                                                           T. parva <br />                                            Human_Calp7                   MIT               PBH <br />                     99                                                                                                                                       C.parvum <br />            58 <br />                                             C.elegans_clp-2 <br />          56                                                                                                     100                      P. tetraurelia <br />                                             PCalp <br />         91                                  Asperg_PalB                                                                                                                  T. therm.                  ? <br />                                                   C.neo_PalB <br />    18                                               Candidal_PalB <br />               80                                     S.cerevisiae_Rim13 <br />                                               Gloeob._Glr4140          HemolysinCabind <br />  <br />          62                                      P.ging_Tpr <br />                                             C.elegans_F44F1.3 <br />  <br /> Fig. 1. Phylogenetic analysis reveals Pcalp distinct type clade calpains. (A) Phylogenetic analysis Pcalp (catalytic domain) aligned representatives <br /> of documented type calpain shown (left side) domain composition protein (right side). Bootstrap values shown tree joints. <br /> Domains color coded named appearance (SMART <span id='am-4' about='Thesaurus:code' typeof='owl:Thing'>code</span>). The Pcalp N terminus subdomains conserved Plasmodium <br /> species (green) (I.R., A.O., D.E.G., unpublished data). Scale fractional change <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> distance. (B) Phylogenetic analysis domain composition alveolate <br /> calpains. Crossed boxes denote incomplete sequence information. Sequence data listed Tables S1 S2 alignments Figs. S1 S2. <br />  <br />  <br />  <br /> coding regions normalizing actin, peak                                       S phase 30 hpi (Fig. 2B), corresponding peak amount <br /> induction (2&#226;&#171;&#187;) late ring/early trophozoite stages [18&#226;&#8364;&#8220;24                                        Pcalp. <br /> hours postinvasion (hpi), Fig. 2A], consistent data of <br /> Bozdech et al. (9).                                                                                    The Pcalp Gene Its Activity Are Essential Optimal Growth. We <br />    Despite low expression levels, able detect Pcalp                                    assessed essentiality Pcalp optimal P. falciparum asexual <br /> by Western blotting immunoprecipitation large num-                                        growth using multiple approaches (Fig. 3A). The a <br /> ber parasites (5 &#226;&#171;&#187; 108). We used parasite line (C3)                                  classical gene <span id='am-241' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-242' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-257' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-285' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-298' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-300' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-303' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-317' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span>knockout</span> approach using double cross-over with <br />                                                                                                        positive/negative selection (11). We used double positive selection <br /> endogenous calpain ORF tagged GFP (see Materials and <br />                                                                                                        fusing HcRed hDHFR obtained red fluorescent parasites <br /> Methods), anti-GFP antibody used visual-                                      stably maintained plasmid drug pressure (Fig. S4). <br /> ization. The asexual cycle monitored morphology DNA                                        However, unable recover integrants negative <br /> content (Fig. 2B). Pcalp detected rings late                                          selection despite multiple attempts, assayed Southern blotting <br /> trophozoites, showing peak cell midtropho-                                      (Fig. 3B) nested PCR (data shown). <br /> zoites concentration (normalized BiP) rings (Fig. 2 C                                        For gene disruption 5&#226;&#172;&#732; single cross-over, transfected 3D7 <br /> and D). In experiments, majority cells entered                                    parasites constructs containing 1.3 1.6 kb 5&#226;&#172;&#732; end of <br />  <br />  <br /> Fig. 2. Expression profiles Pcalp asexual <br /> cycle. (A) Semiquantitative RT-PCR analysis. Expression <br />                                                                 12 <br />                                                                           A                                               ER   LR <br />                                                                                                                                             C <br />                                                                                                                                      ET MT MT/LT Sc <br />                                                                                                                                                       IP: R- -PCalp <br />                                                                 10 <br />                                                                                                                                                       WB: M- -GFP <br />                                                                           calpain/actin <br />  <br />  <br />  <br />  <br /> of Pcalp mRNA asexual stages measured by <br />                                                                            rel intensity <br />  <br />  <br />  <br />  <br />                                                                   8 <br /> quantifying amplified regions encoding N (light                                                                                                      kDa <br />                                                                   6                                                                                      250 <br /> gray) C (dark gray) termini (map region Fig. <br />                                                                   4 <br /> S3). The signals normalized actin. ER LR,                                                                                                    75 <br />                                                                   2                                                                                   IP inputs <br /> early late rings; ET LT, early late tropho-                                                                                               WB:   R - -BiP <br />                                                                   0                                                 hpi    9 19    25    29   33  43 <br /> zoites; Sc, schizonts. (B) Time course Pcalp-GFP                    ER      LR      ET         LT  LT/Sc   Sc <br />  <br /> (clone C3) cycle. Parasites sampled 30 min <br /> and analyzed flow cytometry DNA content.               100         B ER      LR    ET MT MT/LT   Sc <br />                                                                                                                        8 <br />                                                                                                                                           D <br />                                                                           % total parasites <br />  <br />  <br />  <br />  <br />                                                                90 <br /> Populations selected analysis shown Fig.        80                                                      7 <br />                                                                                                                                           arbitrary units <br />  <br />  <br />  <br />  <br /> S3. The percentage total parasites pre-S phase, S        70                                                      6 <br />                                                                60                                                      5 <br /> phase, mature schizogony represented                50                                                      4 <br /> black, red, green lines, respectively. Zero time           40                                                      3 <br /> corresponds peak mature schizonts. Dots        30 <br />                                                                                                                                                                                                            MICROBIOLOGY <br />  <br />  <br />  <br />  <br />                                                                                                                        2 <br />                                                                20 <br /> indicate harvest times protein analysis (MT, midtro-       10                                                       1 <br /> phozoites) arrow marks approximate start            0 <br />                                                                  -5   0   5  10 15 20 25 30 35 40 45 50 55 <br />                                                                                                                        0 <br />                                                                                                                          8 12 16 20 24 28 32 36 40 44 <br /> of S phase. (C) C3 parasites harvested                                     time (hpi)                                  time (hpi) <br /> indicated time points, Pcalp immunoprecipitated rabbit anti-Pcalp antiserum protein blotted mouse anti-GFP antibody. BiP content <br /> was measured. Each lane corresponds equivalent cell numbers different stages. (D) Pcalp levels quantified blots plotted time as <br /> absolute values (red) ratio calpain BiP (black). The point ratio omitted minimal BiP expression early rings. <br />  <br />  <br /> Russo et al.                                                                                                                 PNAS &#229;&#8230;&#169; February 3, 2009 &#229;&#8230;&#169; vol. 106 &#229;&#8230;&#169; no. 5 &#229;&#8230;&#169; 1555 <br />  A                                                                                   Bi <br />  <br />  <br />  <br />  <br />                                                                                                                   m <br />                                                                                                         f. <br />                                                                                                                            ii                                                                           v <br />  <br />  <br />  <br />  <br />                                                                                                       ns <br />                                                                                                                                                   iii                             iv <br />  <br />  <br />  <br />  <br />                                                                                                                  as <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                        7 <br />                       5&#226;&#8364;&#8482;region            HcRed-hDHFR      3&#226;&#8364;&#8482; region <br />  <br />  <br />  <br />  <br />                                                                                               7 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                          7 <br />                                                                                                                                             kb                                                                         kb <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                       3D <br />                                                                                                                       kb                                                     kb <br />  <br />  <br />  <br />  <br />                                                                                           3D <br />  <br />  <br />  <br />  <br />                                                                                                                                                                      3D <br />                                                                                                   tr a <br /> i <br />  <br />  <br />  <br />  <br />                                                                                                          pl <br />                                                                                                                       11                     8                                8                                         8 <br />                                      TK       X                                                                                              7                                7                                         7 <br />                                                                                                                        9                     6                                                                          6 <br />                                                                                                                        8                                                      6 <br />                                                                                                                        7                    5                                                                           5 <br />                     nat 5&#226;&#8364;&#8482; N-term          GFP Ahsp86-3&#226;&#8364;&#8482;   ,hDHFR                                                                                                             5 <br /> ii              S                                  N                   S                                               6                    4                                 4                                         4 <br />             1                                                                                                          5 <br />                       *                                                             Ci     NS(I)         NS(II)                S        3D7                 ii           NS            S       Plasmids 3D7 <br />                     BstUI             Pcalp 3&apos;                                                                                                        kb                                                               kb <br /> iii                                                                                   2                                                              1.6         1                                                    1.6 <br />                                                                                                                                                      1.0                                                              1.0 <br />                                  2        1                   S                                                                                      0.8                                                              0.8 <br />       N P                                                                       P <br /> iv <br />                                                   *                                                                                                  0.5 <br />                                                                                                                                                      0.3                                                              0.5 <br />                                                                                                                                                                                                                       0.3 <br />        nat 5&#226;&#8364;&#8482;                                 Pcalp                                                                                                  0.1 <br />                                                                                           -       +          -        +    -       +    -     +     BstUI            -        +   -        +    -   +       -      + BstUI <br />         D a.         Q G F V/V A D C/C S F L S S L T                       b.    Q G F V A D C S F L S S L T                                                iii      clone 1 clone 2 clone 3 clone 4                    kb <br />                     CAAGGTTTTGTTGCGGATTGTTCTTTTCTGTCTTCATTAAC                   CAAGGTTTTGTTGCGGATTGTTCTTTTCTGTCTTCATTAAC                                        2                                                     1.6 <br />                                C        C                  S                                                                           NS <br />                                                                                                                                                                                                                      1.0 <br />                                                                                                                                                                                                                      0.8 <br />                                                                                                                                                                                                                      0.65 <br />                                                                                                                                                                                                                      0.5 <br />                                                                                                                                                                          -    +    -       +   -    +       -     + BstUI <br />  <br /> Fig. 3. Attempted genetic strategies disrupt calpain functionality. (A) Diagrams vectors. (i) For double cross-over <span id='am-319' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-320' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-340' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-342' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-345' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-347' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-349' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-356' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-359' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-360' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-361' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-364' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-365' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-366' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-368' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-375' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-379' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-383' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-393' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-396' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span>gene knockout</span>, positive selection cassette <br /> containing HcRed-hDHFR fusion flanked Pcalp ORF 5&#226;&#172;&#732; 3&#226;&#172;&#732; ends inserted thymidine kinase (TK) negative selection vector. (ii) For single cross-over <br /> gene disruption, sequence homologous Pcalp ORF 5&#226;&#172;&#732; end cloned upstream hDHFR cassette. Two different lengths (1.3 1.6 kb) used. Control <br /> constructs identical contain 733 bp upstream sequence (nat 5&#226;&#172;&#732;, brackets). (iii) For allelic replacement, sequence homologous 3.8 kb Pcalp ORF 3&#226;&#172;&#732; <br /> end used homologous recombination. Two plasmids created. Both <span id='am-163' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-164' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span>mutation</span> creating new restriction site (BstUI). Two codons downstream in <br /> the active site cysteine codon (*), synonymous change, nonsynonymous change. Predicted products integration ii iii are <br /> shown Fig. S4. (iv) For reference Pcalp gene shown. Primers used PCR/restriction allelic replacement strategy indicated (semiarrows). Restriction <br /> sites: X, XmaI; N, NsiI; S, SphI; P, PacI. (B) Southern blot analysis. (i) Double cross-over. Transfected parasite DNA (X/P digested) shows uninterrupted endogenous <br /> gene (open arrow) episomal plasmid (gray arrow), evidence integration event (filled arrows). Each panel different exposure time. (ii&#226;&#8364;&#8220;v) Single <br /> cross-over. DNA restricted N/S. All 4 transfections control vector predicted integrations (ii iii; panels 2 blots). None 4 <br /> transfections vectors gene disruption (iv v) evidence integration events (panels blot). Arrows i. 1.6-kb 5&#226;&#172;&#732; ORF ii and <br /> iv; 1.3-kb 5&#226;&#172;&#732; ORF iii v; nat 5&#226;&#172;&#732; ii iii. 3D7, genomic DNA parental isolate. (C) PCR restriction screening. DNA prepared parasite culture <br /> transfected synonymous (S) nonsynonymous (NS) vector selected integrants. (i) PCR performed using primer 2 amplify transcribed locus <br /> but plasmids. Product incubated (&#226;&#171;&#185;) (&#226;&#171;&#186;) BstUI (below) arrows indicate expected fragments. The S vector transfectants showed evidence <br /> of upstream cross-over (introduction restriction site), NS vector transfectant pools did. (ii) PCR performed using primer 1 amplify copies <br /> (including plasmid) transfectants isolated plasmids (1:1 mix S NS). Both isolated transfected episomal plasmids restrictable. 3D7, B. <br /> (iii) Examples isolated S clones. PCR performed primer 2; 1 4 clones shown crossed-over upstream. (D) Sequencing PCR products amplified from <br /> S (i) NS (ii) integrant pools. Results control sequence analysis plasmids wild-type genomic amplicons Fig. S4. <br />  <br />  <br />  <br /> Pcalp (Fig. 3Aii). As controls used second pair constructs,                                          active site, one-third S mutation pool an <br /> identical previous ones including additional 733 bp                                            alteration codon (Fig. 3D). As control, amplified and <br /> upstream Pcalp ORF. These controls, integration,                                                 digested active site region parental 3D7 genome, the <br /> recapitulate functional 5&#226;&#172;&#732; UTR ahead Pcalp ORF,                                                2 plasmids isolated DNA episomes transfections <br /> whereas disruption constructs designed generate                                                 (Fig. 3Cii). We confirmed absence restrictability the <br /> promoterless ORF addition truncated copy. All transfec-                                            parental genome, introduction BstUI sensitivity due <br /> tions repeated twice resulted transformants                                            uniquely plasmids, similarity DNA content among <br /> were subjected selection integrants. Although promoter-                                           selected transfectants. <br /> containing constructs showed clear integration (Fig. 3Bii iii),                                          We completed study isolating clones the <br /> integration detectable promoterless constructs (Fig.                                             transfections better quantify proportion upstream inte- <br /> 3Biv v). These results strongly suggest Pcalp essential                                      grants. We isolated nearly 100 clones screened PCR product <br /> parasite growth. The data imply 733 bp upstream                                             restrictability, described (examples Fig. 3Ciii). Out 62 <br /> the ORF adequate drive calpain expression maintain                                              NS mutation plasmid-transfected clones, detected with <br /> viability.                                                                                                   upstream integration, &#226;&#172;&#8225;21% isolated S <br />                                                                                                              mutation transfection carried newly introduced restriction site and <br />    To assess Pcalp essentiality determine proteolytic <br />                                                                                                              consequently mutated cysteine codon. These data indicate that <br /> activity enzyme required, generated 2 identical <br />                                                                                                              essentiality Pcalp depends proteolytic activity. Results <br /> allelic replacement plasmids carrying 3&#226;&#172;&#732;-most two-thirds the <br />                                                                                                              attempts summarized Table 1. <br /> Pcalp ORF (Fig. 3Aiii). Two mutations made. The first, <br /> common plasmids, <span id='am-397' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-398' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-399' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-400' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-402' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-403' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-404' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-405' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-406' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-407' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-408' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-409' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-410' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-411' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-412' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-413' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-414' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-415' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-416' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-417' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-418' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-419' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-420' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-421' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-422' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-423' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-424' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-425' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-426' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-427' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-428' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-429' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-430' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-431' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-432' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-433' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-434' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-435' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-436' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-437' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-438' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-439' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-440' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-441' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-442' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-444' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-445' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-446' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-447' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-448' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-449' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-450' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-451' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-452' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-453' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-454' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-455' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-456' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-457' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-458' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-459' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-460' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-461' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-462' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-463' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-465' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-466' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-467' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-468' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-469' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-470' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-471' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-472' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-473' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-474' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span>silent mutation</span> creates new                                            Conditional Knockdown Pcalp. Since disruption calpain <br /> restriction site. The second mutation, 2 codons downstream                                            gene unachievable, study function protein vivo <br /> catalytic cysteine triplet, synonymous (S) nonsynony-                                          attempted generate conditional knockdown, taking advan- <br /> mous (NS) (Cys&#226;&#172;&#381;Ala). We transfected 3D7 parasites selected                                               tage FKBP destabilization domain (12). The 10-kDa <br /> for integrants. Cross-over occur upstream downstream                                           FKBP domain, fused protein interest, targets for <br /> catalytic cysteine codon. Assuming cross-over random                                            degradation. However, presence small-molecule FKBP <br /> the 3,815 bp homologous sequence, probability integration                                          ligand, Shld1, degradation mitigated. This shown <br /> upstream new restriction site 22%, downstream                                               work Plasmodium episomally expressed constructs (13). To <br /> active site codon 78%, 0.16%. When                                                 create conditional protein knockdown, tagged Pcalp C <br /> specifically PCR-amplified transcribed calpain locus,                                           terminus GFP-FKBP homologous recombination 3&#226;&#172;&#732; <br /> BstUI-restrictable product derived S mutation integrant                                             end endogenous locus (Fig. 4A). After drug cycling with <br /> pool (Fig. 3Ci), indicating upstream cross-over occurs                                             culture constantly exposed 0.5 &#226;?&#174;M Shld1, obtained successful <br /> when active site cysteine changed. We directly                                               integration (Fig. 4B). Clones isolated representative <br /> sequenced amplicons did detect NS mutation                                                one, A7, chosen study. <br />  <br /> 1556 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0806926106                                                                                                                                                             Russo et al. <br />                          Table 1. Calpain gene disruption attempts <br />                         Method                                      Purpose                          Outcome                       Attempts <br />                         Double cross-over                    Gene knockout                      0 integrations                         6 <br />                         Single cross-over                    Gene recapitulation                4 integrations                         4 <br />                                                              Gene disruption                    0 integrations                         4 <br />                         Allelic replacement                  Synonymous mutation                7 mutations/33 clones                  1 <br />                                                              Nonsynonymous mutation             0 mutations/62 clones                  2 <br />  <br />  <br />  <br />  <br />    We analyzed Pcalp-GFP-FKBP obtained                              fixed cells. We calculated ratio percent dead <br /> synchronized midtrophozoites grown presence absence                       parasites detected versus Shld1 (Fig. 5F). For A7, the <br /> Shld1. Despite low expression level, able                          dead cells absence Shld1 consistently &#226;&#172;&#8225;1.5 <br /> visualize drop calpain removal Shld1 (Fig. 4C). The                       times culture maintained Shld1, whereas <br /> experiment repeated 3 times reproducible. The                              C3 control culture ratio steady &#226;&#172;&#8225;1.0. This <br /> immunoprecipitation judged successful Shld1-minus lane                      difference confirmed 3 techniques correlates <br /> because IgG precipitated comparable                       decreased parasitemia detected. <br /> the Shld1-plus lane. There low molecular weight GFP-                              We analyzed microscopy appearance dead <br /> positive bands indicated degradation sample                     parasites. Topro3-positive parasites, detected cultures or <br /> workup (not shown). As control used C3, Pcalp-GFP                       Shld1, mature schizonts stochastically did <br /> integrant lacks degradation domain. Calpain content                    egress properly (data shown). Surprisingly, A7 calpain <br /> control cells affected. These results strategy                  destabilized removal Shld1, detected appearance <br /> can used create conditional knockdowns P. falciparum.                         type dead cell (Fig. 5G). These cells trophozoites <br />                                                                                        appeared morphologically normal extraerythrocytic <br /> Evidence Important Regulatory Function Pcalp G1. Growth                   inside RBC ghosts, indicating failure homeostasis during <br /> of asynchronous Pcalp-GFP-FKBP-expressing clones depen-                            development. <br /> dent Shld1. Whenever removed Shld1 cultures                             The surviving parasites A7 culture Shld1 not <br /> observed growth inhibition 40&#226;&#8364;&#8220;60% 4 days (Fig. 5 A                       look morphologically abnormal slightly delayed the <br /> B). The control culture (Pcalp-GFP, C3) showed slight <br />                                                                                        transition ring trophozoite (Fig. 5H). Therefore, did <br /> long-term toxicity drug. With increasing concentrations of <br />                                                                                        careful monitoring progression asexual cycle. Using <br /> Shld1, growth improved, reaching maximum &#226;&#172;&#8225;0.4 &#226;?&#174;M (Fig. <br />                                                                                        automated collector, harvested fixed synchronized <br /> 5C), remained constant 1 &#226;?&#174;M (data shown). <br />                                                                                        culture A7 30 min multiple cycles. The samples were <br />    The phenotypic analysis extended synchronized cultures of <br />                                                                                        analyzed DNA content (Fig. S5) counted percent of <br /> A7 C3 clones. Shld1-maintained early schizonts split into <br /> 2 portions (with Shld1) closely monitored                       parasites G1 (1N), S phase (2&#226;&#8364;&#8220;15N), late schizonts (&#226;&#172;&#381;15N). <br /> the cell cycle flow cytometry (Fig. 5 D E). No differences                   Fig. 5I shows 2 representative cycles culture presence <br /> invasion efficiency observed. However, A7 culture                          (Upper) absence (Lower) Shld1. Although substantial <br /> without Shld1, growth defect evident trophozoite stage                    difference cycle <span id='am-5' about='xsp:length' typeof='owl:Thing'>length</span> detected, start S phase the <br /> (&#226;&#172;&#8225;20% decrease parasitemia). The loss parasitemia                            absence Shld1 consistently delayed 3&#226;&#8364;&#8220;3.5 h. This correlates <br /> maintained rest cycle detected                     peak enzyme expression (Fig. 2). Our data indicate that <br /> the cycle. No defect detected control                        Pcalp knockdown leads cell death delay transitioning out <br /> culture.                                                                               G1 phase trophozoite development. <br />    To better understand drop parasitemia ring/ <br /> trophozoite transition, tested viability A7 C3                       Discussion <br /> cultures cycle. Three different measurements                  We characterized distinct type calpain only <br /> made using combinations dyes stain metabolically active                     Apicomplexa alveolates. It unique N-terminal <br /> cells (CM green), live dead cells (Syto-59 Acridine Orange                     domain, constitutes half entire protein. The marked <br /> [AcOr]), dead cells (Topro3). The signals pair                      divergence mammalian calpains presence number <br /> dyes (Syto&#226;&#171;&#185;CM, Topro&#226;&#171;&#185;CM, Topro&#226;&#171;&#185;AcOr) detected                                  clinically relevant apicomplexans make enzyme attractive <br /> FITC APC channels compared staining obtained                          target studied. <br />  <br />  <br />   A                                                                             B     3D7 Sel1 Sel2 Sel3      clones              C IP: R-   -GFP WB: M- -GFP <br />                                                                                                                              kb             A7           C3 <br />       N                                          S              N   500bp                                                               -        +   -        + Shield-1 <br />                                                                                                                             6.0 <br />                               Pcalp                                                                                         5.0 <br />                                       S                               N                                                     4.0 <br />                                                                                                                                                                    kDa <br />                           hDHFR                         GFP-FKBP                                                            3.0 <br />                                           Integration                                                                                                             250 <br />   N                                            S                            N                                                      IP inputs: <br />                                                                                                                                                                    75 <br />                     N                                                                                                       2.0                                   -BiP <br />                                                      probe     GFP-FKBP <br />                                                                                                                                                                   -PM2 <br />            C-term                                                                                                           1.0 <br />                                                                                                                                                                    25 <br />                                                                                                                                                                            MICROBIOLOGY <br />  <br />  <br />  <br />  <br /> Fig. 4. Knockdown Pcalp. (A) Creation calpain-GFP-FKBP chimera homologous recombination. The diagram shows strategy create C-terminally <br /> tagged calpain integration endogenous locus. The plasmid contains sequence Pcalp ORF 3&#226;&#172;&#732; end frame GFP-FKBP. Relative positions <br /> of NsiI (N) SphI (S) restriction sites, probe indicated. (B) Southern blot N/S restricted DNA 3 drug cycles (Sel1&#226;&#8364;&#8220;3) 3 clones. Arrows: <br /> endogenous gene (black), plasmid (gray), modified calpain locus (open). (C) Western blot immunoprecipitated Pcalp-GFP (C3) Pcalp-GFP-FKBP (A7) <br /> parasites grown presence absence Shld1. Samples processed Fig. 2B. Each lane corresponds equivalent numbers mid/late trophozoites. <br />  <br />  <br /> Russo et al.                                                                                                PNAS &#229;&#8230;&#169; February 3, 2009 &#229;&#8230;&#169; vol. 106 &#229;&#8230;&#169; no. 5 &#229;&#8230;&#169; 1557 <br />            13.5                                                      D 1211 <br />   A12 A7                                                                                              A7                 Ring <br />  <br />                                                                                                 10                                                                   G         merges    Topro3 Hoechst        Phase         H   - Shld1      + Shld1 <br />           10.5                                                                                                                          Ring <br />                                                                                                  9                                                                        a. <br />   parasitemia (%) <br />  <br />  <br />  <br />  <br />                                                                         parasitemia (%) <br />              9                                                                                   8 <br />                          7.5                                                                     7 <br />                                                                                                  6 <br />                            6                                                                     5 <br />                                                                                                  4 Ring <br />                                                                                                                                                                           b. <br />                          4.5 <br />                            3                                                                     3 <br />                                                                                                  2                              Troph <br />                          1.5                                                                                  Troph <br />                                                                                                  1 <br />                                                                                                    E Schiz <br />                           0                                                                      0 <br />  <br />  <br />   B 109 C3                                                          E 1211                            C3                 Ring           Ring      I100                                                                                          +Shld1 <br />                                                                                                 10                                                                   80 <br />                           8 <br />                                                                                                  9 <br />                                                                         parasitemia (%) <br />   parasitemia (%) <br />  <br />  <br />  <br />  <br />                           7                                                                      8 <br />                           6                                                                      7                                                                   60                            pre S-phase = 25.5 0.5h <br />                           5                                                                      6 <br />                           4                                                                      5                                                                   40 <br />                                                                                                      Ring                                                                                         Cycle time = 42.5 0.5h <br />  <br />  <br />  <br />  <br />                                                                                                                                                %of total parasites <br />                                                                                                  4 <br />                           3 <br />                                                                                                  3 <br />                           2                                                                      2                              Troph                         20 <br />                           1                                                                      1            Troph <br />                                                                                                     E Schiz                                                    0 <br />                           0                                                                      0 <br />                            0.5 1    1.5      2 2.5 3      3.5   4                                 0      20      40     60      80       100 <br />                                           time (days)                                                           time (hours)                                 100                                                                                -Shld1 <br />                                                                                                                                                               80 <br />  C100 <br />    90 <br />                                                                      F1.82 <br />                                                                     dead par (%) -/+ Shld1 <br />  <br />  <br />  <br />  <br />                          80                                                                     1.6 <br />                                                                                                                                                                      60                            pre S-phase = 28.5 1h <br />   % total parasites <br />  <br />  <br />  <br />  <br />                          70                                                                     1.4 <br />                          60                                                                     1.2                                                                  40                           Cycle time = 42 0.5h <br />                          50                                                                       1 <br />                          40                                                                     0.8                                                                  20 <br />                          30                                                                     0.6 <br />                          20                                                                     0.4 <br />                                                                                                 0.2 <br />                                                                                                                                                                       0 <br />                          10                                                                                                                                           -15 -10       -5    0   5      10 15 20 25 30 35 40                  45 50 55 60 <br />                           0                                                                       0 <br />                            0       0.1       0.2    0.3     0.4                                       Syto+CM     Topro+CM      Topro+AcOr                                                                 time (hpi) <br />                                          Shld1 ( M) <br />  <br /> Fig. 5. Analysis Pcalp knockdown phenotypes. (A B) Asynchronous cultures representative clone A7 (A) C3 (B) grown (F) (E) <br /> 0.4 &#226;?&#174;M Shld1 monitored time flow cytometry. X axis A B. (C) Growth Pcalp-GFP-FKBP (mean 3 clones, F) C3 (&#228;&#352;?) 3 days in <br /> different Shld1 concentrations. (D E) Fine analysis Shld1 growth <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span>phenotype</span> synchronized cultures A7 (D) C3 (E). Schizonts culture <br /> grown 0.2 &#226;?&#174;M Shld1 isolated allowed reinvade fresh RBCs presence (F) absence (E) Shld1. The breaks indicate equal subculture <br /> event culture. X axis D E. (F) Viability measurements using different dyes measure dead parasites A7 (light) C3 (dark) cultures. <br /> The ratio &#226;&#171;&#186;/&#226;&#171;&#185; 0.2 &#226;?&#174;M Shld1 plotted. Flow profiles Fig. S5. (G) Appearance A7 dead parasites (Topro3-positive) fluorescence microscopy. In the <br /> absence Shld1 unique dead species detected: trophozoites extraerythrocytic (a) RBC ghosts (b). (H) Giemsa-stained smears <br /> showed delay morphological transition ring trophozoite synchronized A7 cultures absence Shld1. (I) Representative cycles A7 with <br /> (Upper) (Lower) Shld1. Cycle points acquired 30 min &#226;&#172;&#8225;6 days, samples fixed, DNA content analyzed flow cytometry <br /> (Fig. S3). Green, mature schizonts; red, S phase; black, pre-S phase (G1). The cycle time shown distance 2 peaks schizonts; length pre-S <br /> phase time separating initial slope half maxima pre-S-phase S-phase peaks. Red vertical lines indicate S-phase maxima &#226;&#171;&#185;Shld1 visual <br /> comparison &#226;&#171;&#186;Shld1 culture. A consistent delay start S phase detected calpain destabilized. <br />  <br />  <br />  <br />     Multiple efforts generate parasite clone lacking calpain                                                                                         calpain stability regulated small molecule Shld1. <br /> expression failed, strongly suggesting absence gene                                                                                      Destabilization Pcalp yielded growth defect 40&#226;&#8364;&#8220;60% 2 <br /> is incompatible optimal viability blood stages. We used                                                                                       cycles. We measured delay entry S phase. Morphologically, <br /> 3 different techniques. The double cross-over gene knockout                                                                                               transition ring trophozoite delayed. Concom- <br /> approach failed generate recombinants. Disruption single                                                                                            itantly detected increased number nonviable parasites. <br /> cross-over 5&#226;&#172;&#732; end endogenous locus, including control                                                                                     Peaks Pcalp transcription translation normal parasites <br /> for homologous recombination, new approach. Only                                                                                            seen pre-S-phase stages (ring mid trophozoite), after <br /> native promoter recapitulated did recombination result                                                                                         sudden drop levels detected. This correlates nicely <br /> viable parasites. It possible technical problems led                                                                                    observed knockdown phenotype. <br /> failure isolate gene-disrupted recombinants 2 proce-                                                                                            In absence Shld1, fusion protein degraded, resulting <br /> dures. Therefore, designed approach, allelic replace-                                                                                       knockdown effect. The remarkably scarce transcript barely <br /> ment, overcome limitation. We readily able isolate                                                                                        detectable protein levels provided challenges detection and <br /> parasites cross-overs upstream active cysteine codon,                                                                                      study calpain. The normal level calpain low we <br /> the predicted frequency, vector contained synonymous                                                                                           quantify precisely extent protein diminution. How- <br /> active site mutation. In contrast, recombinants downstream                                                                                       ever, FKBP fusions shown order magnitude <br /> when nonsynonymous mutation vector used. Unlike                                                                                               range response Shld1 (ref. 13 I.R., unpublished results). <br /> first 2 strategies, allelic replacement method generates recom-                                                                                       Assuming small number calpain molecules normal <br /> binants missense mutation vector. It site                                                                                         Gaussian distribution cells, attribute death phenotype <br /> recombination informs gene essentiality. In addition,                                                                                      cells (about 20% parasites) number of <br /> the importance active site residue informs Pcalp                                                                                           calpain molecules insufficient overcome efficiency the <br /> activity necessary asexual cycle development.                                                                                                      degradation process. Therefore, cells die loss of <br />     These studies insight essentiality help                                                                                    calpain function. The rest cells produce just enough <br /> understand role enzyme cell. To pursue this,                                                                                         calpain survive, defect pre-S-phase <br /> developed method, based FKBP degradation domain (12,                                                                                             development. The total cell cycle time normal surviving <br /> 13), generate regulated knockdown Pcalp. By fusing                                                                                              parasites, suggesting able catch up. Perhaps cycle <br /> GFP-FKBP tag endogenous locus generated clonal lines                                                                                            clock able proceed normal time, whereas <br />  <br /> 1558 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0806926106                                                                                                                                                                                             Russo et al. <br />  Pcalp affects previous one. Involvement calpain-like activity                              determined according time morphological analysis Giemsa staining. <br /> in G1 3 S transitions suggested systems                                  RNA treated DNase I (Gibco) checked PCR purity. Pcalp cDNA <br /> basis indirect evidence (14, 15). An S-phase delay                               amplified one-step RT-PCR SuperScript (Invitrogen). The RT-PCR <br />                                                                                                   products 2 independent reactions time point analyzed <br /> observed P. berghei parasites lacking 1 2 eEF1a genes, in <br />                                                                                                   ethidium bromide/agarose gels. Band intensity linear range. Primers <br /> that case, total cell cycle prolonged (16). Given role                             Table S3. <br /> cell cycle progression, interesting enzyme found <br /> in nucleolus (I.R., A.O., D.E.G., unpublished data), which,                               Southern Blots. For Southern blots, 1 &#226;?&#174;g DNA digested analyzed as <br /> in addition rRNA synthesis ribosome assembly, key                                      previously described (25). The double cross-over integrations screened by <br /> functions cell cycle regulation (17). In conclusion, developing                             PacI/XmaI digestion probed using Pcalp ORF 5&#226;&#172;&#732; end. The single cross-over <br /> a method regulated knockdown Pcalp, begin define                                 integrations screened NsiI/SphI digestion probing Pcalp ORF 5&#226;&#172;&#732; <br /> its cellular role develop interesting target                                 3&#226;&#172;&#732; end. <br /> antiparasitic chemotherapy. <br />                                                                                                   Western Blots. Protein analysis detect Pcalp immunoprecipitation was <br /> Materials Methods                                                                             conducted described SI Materials Methods. <br /> Reagents. Polyclonal antiserum (no. 19) raised rabbits Pcalp <br /> peptide 41&#226;&#8364;&#8220;54. We used rabbit anti-GFP ab6556 (Abcam), mouse anti-GFP JL8                    Microscopy Techniques. Live parasites observed presence Hoechst <br /> (BD), rabbit anti-BiP (MR4), rabbit anti-plasmepsin II (18) antibodies. All             33342 Topro3. Images collected Axioskop epifluorescence <br /> reagents purchased Sigma NEB unless indicated.                                microscope (Zeiss) described (25). <br />  <br /> Cell Cultures Transfection. P. falciparum (3D7) cultured previously                    Flow Cytometry. For cell cycle analysis, highly synchronous 2% hematocrit cul- <br /> described (19). Parasite synchronization obtained using 5% D-sorbitol                      tures, 1% parasitemia, cultivated gently rocked Roboflasks (Corning) <br /> treatment (20), Percoll (21), magnetic separation (22). For transfections, 160                ensure cell suspension. An automated system, controlled 3 timers and <br /> &#226;?&#174;l 50% RBCs transfected electroporation (23) &#226;&#172;&#8225;100 &#226;?&#174;g purified                   composed 3 synchronized peristaltic pumps fraction collector, set up. <br /> vector DNA infected 3D7 schizonts. After 72&#226;&#8364;&#8220;90 h, 10 nM WR99210                     Each 30 min, &#226;&#172;&#8225;150 &#226;?&#174;l sample culture extracted the <br /> was added medium. To select integration, parasites cycled twice                   flask septum, sample fixed collected 4 &#194;&#176;C 96-well <br /> on/off drug (24). Double cross-over recombination selected described                    plate. For subculture, fresh, prewarmed RBCs (2% hematocrit) added <br /> ref. 11.                                                                                          septum removing flask incubator. The fixative <br />                                                                                                   solution (1.5 vol sample) 3.2% formaldehyde 0.01% glutaraldehyde <br /> Sequence Phylogenetic Analysis. See SI Materials Methods.                                 PBS. After 5min permeabilization 0.1% Triton X-100 15 min of <br />                                                                                                   incubation &#226;&#172;&#8225;75 &#226;?&#174;g/ml RNase A, cell DNA stained 0.5&#226;&#8364;&#8220;1 &#226;?&#174;M Topro3. <br /> Construction Vectors. Genomic DNAs extracted P. falciparum                        The analysis conducted BD FACSCanto flow cytometer, monitoring <br /> using Blood Mini Kit (Qiagen). Primers restriction sites listed Table S3.            fluorescence profiles infected RBC (Fig. S3). <br /> All cloning steps confirmed sequencing. For gene knockout strategy,                      For viability analysis, used following dyes pairs: 1.25 &#226;?&#174;g/ml Cell <br /> the plasmid pHHTTK (11) modified inserting HcRed coding region                         tracker-green (CM-green), 2.5 &#226;?&#174;M Syto59, 0.5 &#226;?&#174;M Topro3, 0.4 &#226;?&#174;g/ml AcOr <br /> upstream hDHFR. Into backbone, cloned 5&#226;&#172;&#732; 3&#226;&#172;&#732; ends Pcalp                  (Molecular Probes). Metabolically active cells incorporated CM-green a <br /> ORF. Four constructs gene disruption single cross-over. The                      15-min incubation 37 &#194;&#176;C. Then analyzed flow cytometry the <br /> calpain N-terminal coding regions (1.3 1.6 kb) 733 bp 5&#226;&#172;&#732;                   presence DNA dyes, cell-permeant Syto59, cell-impermeant Topro3. The <br /> UTR PCR amplified genomic DNA cloned pPM2GT (25). The                            viability measurement based use 2 DNA dyes time, <br /> vectors allelic replacement generated cloning 3.8 kb Pcalp 3&#226;&#172;&#732; ORF                  AcOr Topro3. Control dead cells produced fixing culture. <br /> into pPM2GT (25). Mutagenesis allelic replacement vectors                    The analysis conducted recording green far-red fluorescence profiles <br /> the QuikChange kit (Stratagene). The vectors 3&#226;&#172;&#732; tagging constructed                   infected RBCs (Fig. S5). <br /> cloning 1.1 kb 3&#226;&#172;&#732; Pcalp ORF pPM2GT (25) generate Pcalp-GFP or <br /> replacing GFP GFP-FKBP generate Pcalp-GFP-FKBP. The FKBP domain                       ACKNOWLEDGMENTS. We thank Sanger Broad Institutes DNA <br /> amplified pBMN YFP-L106P (12).                                                               sequences; Jacobus Pharmaceutical WR99210; T. Wandless (Stanford Uni- <br />   <br /> </body></html>